Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
Provided By GlobeNewswire
Last update: Jan 14, 2025
LEXINGTON, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2024 revenue.
Read more at globenewswire.comNASDAQ:RPID (10/23/2025, 8:00:02 PM)
2.77
+0.03 (+1.09%)
Find more stocks in the Stock Screener
